NasdaqGS:MASIMedical Equipment
Danaher Closes Masimo Deal Shifting Monitoring Story Inside Diagnostics Platform
Danaher has completed its acquisition of Masimo (NasdaqGS:MASI), which will now operate as a standalone subsidiary.
Masimo is being integrated into Danaher’s Diagnostics segment, and its shares have been delisted from Nasdaq.
The transaction ends Masimo’s run as an independent public company and introduces a new leadership structure under Danaher.
For readers who have followed NasdaqGS:MASI as a patient monitoring and healthcare technology stock, this deal reshapes how you think about the...